Pharmacogenetic Markers of Drug Efficacy and Toxicity.

Pharmacogenetic Markers of Drug Efficacy and Toxicity.

Item
http://www.wikidata.org/entity/Q38419534
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion DiagnosticsRationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium.The global spectrum of protein-coding pharmacogenomic diversity.Characterizing the Strength of Evidence in FDA Labels for Pharmacogenomic Biomarker-Guided Medication Use.Transforming Translation: Impact of Clinical and Translational Science.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.Characterization of Three CYP2C19 Gene Variants by MassARRAY and Point of Care Techniques: Experience from a Czech Centre.[Electronic decision support to promote medication safety].History repeats itself: the family medication history and pharmacogenomics.Anticoagulants: Major Advances Without Clear Consensus.
P2860

Pharmacogenetic Markers of Drug Efficacy and Toxicity.

Item
http://www.wikidata.org/entity/Q38419534
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacogenetic Markers of Drug Efficacy and Toxicity.
@en
type
label
Pharmacogenetic Markers of Drug Efficacy and Toxicity.
@en
prefLabel
Pharmacogenetic Markers of Drug Efficacy and Toxicity.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Pharmacogenetic Markers of Drug Efficacy and Toxicity.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698